Chimin Health Management Co., Ltd.

Equities

603222

CNE100002193

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
5.94 CNY +3.30% Intraday chart for Chimin Health Management Co., Ltd. +8.39% -25.84%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Chimin Health Management Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023. CI
Tranche Update on Chimin Health Management Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023. CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Chimin Health Management Secures Exclusive Rights to Japanese Cell Therapy Tech MT
Chimin Health Management Co., Ltd.(XSSC:603222) added to S&P Global BMI Index CI
Chimin Health Management Co., Ltd. announces an Equity Buyback for CNY 120 million worth of its shares. CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chimin Health Management Co., Ltd. authorizes a Buyback Plan. CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chimin Health Management Co., Ltd. announced that it has received CNY 489.999998 million in funding CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Chimin Health Management Co., Ltd. announced that it expects to receive CNY 900 million in funding CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chimin Health Management Co., Ltd.(SHSE:603222) dropped from Shanghai Stock Exchange Health Care Sector Index CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Chimin Health Management Co., Ltd. announced that it has received CNY 241.246533 million in funding from Shanghai Chunda Asset Management Co., Ltd., Shenzhen Zongguan Capital Management Co., Ltd., Caitong Fund Management Co., Ltd., and other investors CI
China stocks rise on infra boost, Sino-U.S. tensions cap gains RE
Chart Chimin Health Management Co., Ltd.
More charts
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603222 Stock
  4. News Chimin Health Management Co., Ltd.
  5. Chimin Health Management Secures Exclusive Rights to Japanese Cell Therapy Tech